Insider · CIK 0001820066
David A Santos
Files at RIGL (RIGEL PHARMACEUTICALS INC). First filing Feb 6, 2024, latest Feb 6, 2024.
In brief
David A Santos files SEC Form 4 as officer at RIGL (RIGEL PHARMACEUTICALS INC). Since Feb 6, 2024, David A Santos has reported 0 open-market buys worth $0 and 1 open-market sell worth $16k, the latest filed on Feb 6, 2024.
A track record needs three past buys with six months of prices behind them; David A Santos has 0, so none is measured yet.
The newest scored trade: sold $16k of RIGL on Feb 2, 2024, filed Feb 6, 2024, scored 30 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
RIGL: RIGEL PHARMACEUTICALS INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | RIGEL PHARMACEUTICALS INC | $16k 14,519 shares | -4% | +58% from low-37% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Feb 5, 2025 | RIGL RIGEL PHARMACEUTICALS INC | 1,796 0.01% of outstanding | $39k | Feb 5, 2025 | $44k |
| Feb 4, 2025 | RIGL RIGEL PHARMACEUTICALS INC | 2,125 0.01% of outstanding | $44k | Feb 4, 2025 | none |
Transactions
Every row this insider has filed, 14 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | RIGL RIGEL PHARMACEUTICALS INC | FTax withholding Common Stock | -874 | $47.50 | $42k | 61,622 | 41 d ago |
| Jun 17, 2026 | RIGL RIGEL PHARMACEUTICALS INC | AGrant or award Employee Stock Option (right to buy)derivative | +7,394 | $0.00 | $0 | 7,394 | Jun 22, 2026 |
| Jun 1, 2026 | RIGL RIGEL PHARMACEUTICALS INC | FTax withholding Common Stock | -874 | $29.86 | $26k | 61,996 | Jun 3, 2026 |
| Feb 17, 2026 | RIGL RIGEL PHARMACEUTICALS INC | AGrant or award Common Stock | +19,430 | $0.00 | $0 | 62,870 | Feb 19, 2026 |
| Feb 10, 2026 | RIGL RIGEL PHARMACEUTICALS INC | FTax withholding Common Stock | -3,546 | $34.62 | $123k | 43,440 | Feb 12, 2026 |
| Feb 2, 2026 | RIGL RIGEL PHARMACEUTICALS INC | FTax withholding Common Stock | -5,718 | $36.01 | $206k | 46,986 | Feb 4, 2026 |
| Sep 15, 2025 | RIGL RIGEL PHARMACEUTICALS INC | AGrant or award Employee Stock Option (right to buy)derivative | +7,394 | $0.00 | $0 | 7,394 | Sep 17, 2025 |
| Nov 25, 2024 | RIGL RIGEL PHARMACEUTICALS INC | AGrant or award Employee Stock Option (right to buy)derivative | +8,000 | $0.00 | $0 | 8,000 | Nov 26, 2024 |
| Feb 28, 2024 | RIGL RIGEL PHARMACEUTICALS INC | AGrant or award Employee Stock Option (right to buy)derivative | +80,000 | $0.00 | $0 | 80,000 | Mar 1, 2024 |
| Feb 28, 2024 | RIGL RIGEL PHARMACEUTICALS INC | AGrant or award Employee Stock Option (right to buy)derivative | +78,500 | $0.00 | $0 | 78,500 | Mar 1, 2024 |
| Feb 2, 2024 | RIGL RIGEL PHARMACEUTICALS INC | SOpen-market sale Common Stock | -5,601 | $1.13 | $6,329 | 358,011 | Feb 6, 2024 |
| Feb 5, 2024 | RIGL RIGEL PHARMACEUTICALS INC | SOpen-market sale Common Stock | -8,918 | $1.14 | $10k | 349,093 | Feb 6, 2024 |
| Jan 23, 2024 | RIGL RIGEL PHARMACEUTICALS INC | AGrant or award Common Stock | +209,000 | $0.00 | $0 | 363,612 | Jan 25, 2024 |
| Jan 23, 2024 | RIGL RIGEL PHARMACEUTICALS INC | AGrant or award Employee Stock Option (Right to Buy)derivative | +157,000 | $0.00 | $0 | 157,000 | Jan 25, 2024 |
Questions about David A Santos
Answered from the filings on this page, as of the latest one.
Is David A Santos buying or selling?
Not in the last 12 months. David A Santos's latest open-market trade on SEC Form 4 was sold $16k of RIGL on Feb 2, 2024.
How did David A Santos's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and David A Santos has 0.
Where does David A Santos file Form 4?
David A Santos has filed Form 4 at RIGL (RIGEL PHARMACEUTICALS INC) as EVP, Chief Commercial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.